Idexx Laboratories — Q1 2025 Earnings Presentation

4 slides from Idexx Laboratories's earnings presentation, May 1, 2025

Slide 1: IDEXX Q1 2025 Earnings Highlights
IDEXX Q1 2025 2024 Earnings Highlights (NASDAQ: (NASDAQ: IDXX) IDXX) Operating Diluted Revenue Profit Earnings Per Share $998M $317M $2.96 Reported growth: +4% 31.7% of Revenue Reported growth: +5% Organic growth: +5% YoY change in basis points: CAG Diagnostics Recurring Reported +70 bps Comparable
Slide 2: 2025 Growth and Financial Performance Outlook
IDEXX Q1 2025 Earnings Highlights (NASDAQ: IDXX) 2025 Growth and Financial Performance Outlook Commentary • Updates full year P&L guidance to incorporate recent FX impacts and benefit from a discrete expense accrual adjustment for a now-concluded litigation matter, while maintaining outlook for stro
Slide 3: U.S. Companion Animal Practice Growth Update
U.S. Companion Animal Practice Growth Update As of March 31, 2025 Total Practice Revenue and Visit Growth Weighted Average Year-over-Year % Change Per Practice* 20% 15% 10% Practice Revenue 5% 4.7% 3%; 2.2% 2.3% 0% 93 Total Visits ee 72.1% -2.6% -2.6% Qi_ Q2 03 O44 Qi Q2 Q3 O Qi Q a3 4 ai Q Q3 4 Qi
Slide 4: Contributors to U.S. Companion Animal Diagnostic Revenue Growth per Practice
U.S. Companion Animal Practice Growth Update As of March 31, 2025 Contributors to U.S. Companion Animal Diagnostic Revenue Growth per Practice** + 6.5% +4.5% Q1’2025 Year-Over-Year Growth (%) - 2.5% + 0.5% ss + 6.5% + 4.0% Q4’2024 - 2.5% + 0.0% + 8.0% + 11.0% Q1 Average 2020-2023 ae + 3.0% a Clinica